XML 51 R77.htm IDEA: XBRL DOCUMENT v3.20.1
Supplemental Guarantor Information - Unaudited Condensed Consolidating Statements of Cash Flow Information (Details) - USD ($)
$ in Thousands
6 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Condensed Financial Statements, Captions [Line Items]    
Net cash (used in) provided by operating activities $ (45,913) $ (83,034)
Cash flows from investing activities:    
Capital expenditures (5,478) (11,508)
Proceeds from sale of fixed assets 136 94
Investments in unconsolidated entities   (4,088)
Advances to/from subsidiaries 0 0
Net cash used in investing activities (5,342) (15,502)
Cash flows from financing activities:    
Repayment of debt (1,150) (5,062)
Borrowings from credit facility 345,000 225,000
Repayment of borrowings from credit facility (95,000) (150,000)
Debt issuance costs 0 (400)
Repurchase of common stock (3,327) (24,004)
Tax payments for stock-based compensation awards (2,661) (1,886)
Stock option exercises and other financing activities (1,854) 278
Advances to/from subsidiaries 0 0
Net cash provided by financing activities 241,008 43,926
Decrease in cash, cash equivalents, and restricted cash 189,753 (54,610)
Cash, cash equivalents, and restricted cash at beginning of period 122,794 153,248
Cash, cash equivalents, and restricted cash at end of period 312,547 98,638
Consolidating Adjustments    
Condensed Financial Statements, Captions [Line Items]    
Net cash (used in) provided by operating activities 0 0
Cash flows from investing activities:    
Capital expenditures 0 0
Proceeds from sale of fixed assets 0 0
Investments in unconsolidated entities   0
Advances to/from subsidiaries 4,100 (43,528)
Net cash used in investing activities 4,100 (43,528)
Cash flows from financing activities:    
Repayment of debt 0 0
Borrowings from credit facility 0 0
Repayment of borrowings from credit facility 0 0
Debt issuance costs   0
Repurchase of common stock 0 0
Tax payments for stock-based compensation awards 0 0
Stock option exercises and other financing activities 0 0
Advances to/from subsidiaries (4,100) 43,528
Net cash provided by financing activities (4,100) 43,528
Decrease in cash, cash equivalents, and restricted cash 0 0
Cash, cash equivalents, and restricted cash at beginning of period 0 0
Cash, cash equivalents, and restricted cash at end of period 0 0
Beazer Homes USA, Inc. | Reportable Legal Entities    
Condensed Financial Statements, Captions [Line Items]    
Net cash (used in) provided by operating activities (14,758) (101,323)
Cash flows from investing activities:    
Capital expenditures 0 0
Proceeds from sale of fixed assets 0 0
Investments in unconsolidated entities   0
Advances to/from subsidiaries (4,218) 44,061
Net cash used in investing activities (4,218) 44,061
Cash flows from financing activities:    
Repayment of debt 0 (5,062)
Borrowings from credit facility 345,000 225,000
Repayment of borrowings from credit facility (95,000) (150,000)
Debt issuance costs   (400)
Repurchase of common stock (3,327) (24,004)
Tax payments for stock-based compensation awards (2,661) (1,886)
Stock option exercises and other financing activities (1,854) 278
Advances to/from subsidiaries 0 0
Net cash provided by financing activities 242,158 43,926
Decrease in cash, cash equivalents, and restricted cash 223,182 (13,336)
Cash, cash equivalents, and restricted cash at beginning of period 85,464 104,796
Cash, cash equivalents, and restricted cash at end of period 308,646 91,460
Guarantor Subsidiaries | Reportable Legal Entities    
Condensed Financial Statements, Captions [Line Items]    
Net cash (used in) provided by operating activities (31,029) 18,324
Cash flows from investing activities:    
Capital expenditures (5,478) (11,508)
Proceeds from sale of fixed assets 136 94
Investments in unconsolidated entities   (4,088)
Advances to/from subsidiaries 0 0
Net cash used in investing activities (5,342) (15,502)
Cash flows from financing activities:    
Repayment of debt (1,150) 0
Borrowings from credit facility 0 0
Repayment of borrowings from credit facility 0 0
Debt issuance costs   0
Repurchase of common stock 0 0
Tax payments for stock-based compensation awards 0 0
Stock option exercises and other financing activities 0 0
Advances to/from subsidiaries 4,100 (43,528)
Net cash provided by financing activities 2,950 (43,528)
Decrease in cash, cash equivalents, and restricted cash (33,421) (40,706)
Cash, cash equivalents, and restricted cash at beginning of period 37,321 47,877
Cash, cash equivalents, and restricted cash at end of period 3,900 7,171
Non-Guarantor Subsidiaries | Reportable Legal Entities    
Condensed Financial Statements, Captions [Line Items]    
Net cash (used in) provided by operating activities (126) (35)
Cash flows from investing activities:    
Capital expenditures 0 0
Proceeds from sale of fixed assets 0 0
Investments in unconsolidated entities   0
Advances to/from subsidiaries 118 (533)
Net cash used in investing activities 118 (533)
Cash flows from financing activities:    
Repayment of debt 0 0
Borrowings from credit facility 0 0
Repayment of borrowings from credit facility 0 0
Debt issuance costs   0
Repurchase of common stock 0 0
Tax payments for stock-based compensation awards 0 0
Stock option exercises and other financing activities 0 0
Advances to/from subsidiaries 0 0
Net cash provided by financing activities 0 0
Decrease in cash, cash equivalents, and restricted cash (8) (568)
Cash, cash equivalents, and restricted cash at beginning of period 9 575
Cash, cash equivalents, and restricted cash at end of period $ 1 $ 7